Taipei Veterans General Hospital and NYU Langone Health Forge Collaborative Partnership in Heavy Ion Cancer Therapy

Taipei Veterans General Hospital (TVGH) has solidified its position as a leading institution in advanced cancer treatment with the establishment of a collaborative partnership with NYU Langone Health. The partnership, formalized through a memorandum of understanding (MOU), marks NYU Langone's inaugural international collaboration in heavy ion therapy.

President Chen Wei-Ming emphasized the strategic importance of the collaboration, stating, "This partnership provides a robust platform for international exchange and signifies a strengthened alliance in the medical domain. By combining our expertise, we aim to elevate the standard of clinical cancer care and accelerate the development and dissemination of cutting-edge medical technologies across international boundaries."

The MOU, signed during a collaborative exchange meeting held at TVGH, will facilitate a program wherein patients from NYU Langone Health will be referred to TVGH for heavy ion therapy. Furthermore, the two institutions will engage in joint research and development initiatives aimed at refining and advancing heavy ion treatment modalities.

The collaboration was significantly facilitated by Mr. Koo Chung-Li, a member of the NYU Langone Health Board of Trustees. The MOU was executed by TVGH President Chen Wei-Ming and Robert I. Grossman, MD, CEO of NYU Langone Health and Dean of NYU Grossman School of Medicine.

NYU Langone Health, a globally recognized medical center consistently ranked among the world's top hospitals, including its recent inclusion in Newsweek's 2025 list of top 250 hospitals alongside TVGH, has demonstrated a keen interest in TVGH's pioneering work in heavy ion therapy. The collaboration was catalyzed by the significant clinical outcomes achieved by TVGH since the launch of its heavy ion cancer treatment program in May 2024. Notably, the hospital’s advancements in pancreatic cancer treatment have garnered particular attention.

This strategic alliance underscores the growing importance of international collaboration in advancing medical innovation and patient care.

Contact Us